Toll-Like Receptors (TLRs): The Role in Tumor Progression

por Shcheblyakov, D.V., Logunov, D.Y., Tukhvatulin, A.I., Shmarov, M.M., Naroditsky, B.S., Gintsburg, A.L.
Publicado 2010

Triggering of Toll-like Receptor-2 in Mouse Myelomonocytic Leukaemia Cells WEHI-3B Leads to the Suppression of Apoptosis and Promotes Tumor Progression in Vivo

por Shcheblyakov, D.V., Logunov, D.Y., Rakovskaya, I.V., Shmarov, M.M., Naroditsky, B.S., Ginzburg, A.L.
Publicado 2011

An Efficient Method for the Delivery of the Interleukin-2 Gene to Human Hematopoietic Cells using the 
Fiber-Modified Recombinant Adenovirus

por Rogozhin, V.N., Logunov, D.Yu., Shchebliakov, D.V., Shmarov, M.M., Khodunova, E.E., Galtseva, 
I.V., Belousova, R.V., Naroditsky, B.S., Gintsburg, A.L.
Publicado 2011

Regulation of the Target Protein (Transgene) Expression in the Adenovirus Vector Using Agonists of Toll-Like Receptors

por Bagaev, A. V., Pichugin, A. V., Lebedeva, E. S., Lysenko, A. A., Shmarov, M. M., Logunov, D. Yu., Naroditsky, B. S., Ataullakhanov, R. I., Khaitov, R. M., Gintsburg, A. L.
Publicado 2014

A In Vitro and In Vivo Study of the Ability of NOD1 Ligands to Activate the Transcriptional Factor NF-kB

por Tukhvatulin, A.I., Logunov, D.Y., Gitlin, I.I., Shmarov, M.M., Kudan, P.V., Adzhieva, А.А., Moroz, A.F., Kostyukova, N.N., Burdelya, L.G., Naroditsky, B.S., Gintsburg, A.L., Gudkov, A.V.
Publicado 2011

Induction of a Protective Heterosubtypic Immune Response Against the Influenza Virus by using Recombinant Adenoviral Vectors Expressing Hemagglutinin of the Influenza H5 Virus

por Shmarov, M.M., Sedova, E.S., Verkhovskaya, L.V., Rudneva, I.A., Bogacheva, E.A., Barykova, Yu.A., Shcherbinin, D.N., Lysenko, A.A., Tutykhina, I.L., Logunov, D.Y., Smirnov, Yu.A., Naroditsky, B.S., Gintsburg, A.L.
Publicado 2010

Construction of a pIX-modified Adenovirus Vector Able to Effectively Bind to Nanoantibodies for Targeting

por Garas, M. N., Tillib, S. V., Zubkova, O. V., Rogozhin, V. N., Ivanova, T. I., Vasilev, L. A., Logunov, D. Yu., Shmarov, M. M., Tutykhina, I. L., Esmagambetov, I. B., Gribova, I. Yu., Bandelyuk, A. S., Naroditsky, B. S., Gintsburg, A. L.
Publicado 2014

Virus-Vectored Ebola Vaccines

por Dolzhikova, I.V., Tokarskaya, E.A., Dzharullaeva, A. S., Tukhvatulin, A. I., Shcheblyakov, D. V., Voronina, O.L., Syromyatnikova, S. I., Borisevich, S. V., Pantyukhov, V. B., Babira, V. F., Kolobukhina, L. V., Naroditsky, B. S., Logunov, D. Y., Gintsburg, A. L.
Publicado 2017

Non-thermal Plasma Causes p53-Dependent Apoptosis in Human Colon Carcinoma Cells

por Tuhvatulin, A.I., Sysolyatina, E.V., Scheblyakov, D.V., Logunov, D.Yu., Vasiliev, M.M., Yurova, M.A., Danilova, M.A., Petrov, O.F., Naroditsky, B.S., Morfill, G.E., Grigoriev, A.I., Fortov, V.E., Gintsburg, A.L., Ermolaeva, S.A.
Publicado 2012

Immunogenicity of Different Forms of Middle East Respiratory Syndrome S Glycoprotein

por Ozharovskaia, T. A., Zubkova, O. V., Dolzhikova, I. V., Gromova, A. S., Grousova, D. M., Tukhvatulin, A. I., Popova, O., Shcheblyakov, D. V., Scherbinin, D. N., Dzharullaeva, A. S., Erokhova, A. S., Shmarov, M. M., Loginova, S. Y., Borisevich, S. V., Naroditsky, B. S., Logunov, D. Y., Gintsburg, A. L.
Publicado 2019

Nanobodies Are Potential Therapeutic Agents for the Ebola Virus Infection

por Esmagambetov, I. B., Shcheblyakov, D. V., Egorova, D. A., Voronina, O. L., Derkaev, A. A., Voronina, D. V., Popova, O., Ryabova, E. I., Shcherbinin, D. N., Aksenova, E. I., Semenov, A. N., Kunda, M. S., Ryzhova, N. N., Zubkova, O. V., Tukhvatulin, A. I., Logunov, D. Yu., Naroditsky, B. S., Borisevich, S. V., Gintsburg, A. L.
Publicado 2021

Preclinical Studies of Immunogenity, Protectivity, and Safety of the Combined Vector Vaccine for Prevention of the Middle East Respiratory Syndrome

por Dolzhikova, I. V., Grousova, D. M., Zubkova, O. V., Tukhvatulin, A. I., Kovyrshina, A. V., Lubenets, N. L., Ozharovskaia, T. A., Popova, O., Esmagambetov, I. B., Shcheblyakov, D. V., Evgrafova, I. M., Nedorubov, A. A., Gordeichuk, I. V., Gulyaev, S. A., Botikov, A. G., Panina, L. V., Mishin, D. V., Loginova, S. Y., Borisevich, S. V., Deryabin, P. G., Naroditsky, B. S., Logunov, D. Y., Gintsburg, A. L.
Publicado 2020

Safety and immunogenicity of GamEvac-Combi, a heterologous VSV- and Ad5-vectored Ebola vaccine: An open phase I/II trial in healthy adults in Russia

por Dolzhikova, I. V., Zubkova, O. V., Tukhvatulin, A. I., Dzharullaeva, A. S., Tukhvatulina, N. M., Shcheblyakov, D. V., Shmarov, M. M., Tokarskaya, E. A., Simakova, Y. V., Egorova, D. A., Scherbinin, D. N., Tutykhina, I. L., Lysenko, A. A., Kostarnoy, A. V., Gancheva, P. G., Ozharovskaya, T. A., Belugin, B. V., Kolobukhina, L. V., Pantyukhov, V. B., Syromyatnikova, S. I., Shatokhina, I. V., Sizikova, T. V., Rumyantseva, I. G., Andrus, A. F., Boyarskaya, N. V., Voytyuk, A. N., Babira, V. F., Volchikhina, S. V., Kutaev, D. A., Bel'skih, A. N., Zhdanov, K. V., Zakharenko, S. M., Borisevich, S. V., Logunov, D. Y., Naroditsky, B. S., Gintsburg, A. L.
Publicado 2017